Danaher (DHR)
(Delayed Data from NYSE)
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Danaher (DHR) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 1.59% and 1.71%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
General Electric (GE) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
General Electric's (GE) fourth-quarter 2019 earnings benefit year over year on improved margin profile. It remains committed to expanding growth opportunities.
Danaher (DHR) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Danaher's (DHR) fourth-quarter earnings and organic sales results are expected to reflect gains from strong Diagnostics and Life Sciences segments. High costs and forex woes might have ailed.
Analysts Estimate Danaher (DHR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Near-Term View Bleak for Diversified Operations Industry
by Payal Jalan
The US-China trade war, forex woes, geopolitical issues, high debt, diversification issues and other factors are hurting conglomerates. Growth in some end markets and favorable polices are tailwinds.
Danaher (DHR) Raises Earnings & Sales Projections for Q4
by Zacks Equity Research
Danaher's (DHR) fourth-quarter 2019 organic sales and earnings results are predicted to be better than that mentioned previously, driven by healthy performance of the Life Sciences and Diagnostics segments.
The Market Timing Secrets No One Talks About - December 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
The Zacks Analyst Blog Highlights: Danaher, Petrobras, Fiserv, CME and ConocoPhillips
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher, Petrobras, Fiserv, CME and ConocoPhillips
General Electric's (GE) GECAS Unit Divests PK AirFinance
by Zacks Equity Research
General Electric's (GE) aviation services unit completes the divestment of PK AirFinance. This is aligned with the company's plan to divest GE Capital's assets worth $10 billion in 2019.
Top Stock Reports for Danaher, Petrobras & Fiserv
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Danaher (DHR), Petrobras (PBR) and Fiserv (FISV).
Danaher to Lower Stake in Envista, Finalizes Exchange Ratio
by Zacks Equity Research
Danaher (DHR) sets the exchange ratio for each share of Danaher common stock at 5.5784 shares of Envista common stock.
The Market Timing Secrets No One Talks About - December 10, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
ITT or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
ITT Share Price Increases 46% YTD: What's Driving the Rally?
by Zacks Equity Research
ITT rises on solid financial performance, impressive growth prospects, solid product portfolio, focus on innovation, buyouts and shareholder-friendly policies.
Acquired Assets Aid Danaher (DHR) Despite Rise in Costs
by Zacks Equity Research
Danaher's (DHR) acquisitive nature has been driving its top line. High product demand and shareholder-friendly policies are added positives. However, high costs, forex woes and debts are concerning.
Simple Market Timing Strategies That Work - November 19, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Danaher (DHR) Catches Eye: Stock Jumps 5%
by Zacks Equity Research
Danaher (DHR) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
ITT vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
Top Analyst Reports for Mastercard, UnitedHealth & Merck
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), UnitedHealth Group (UNH) and Merck (MRK).
General Electric (GE) Tops Q3 Earnings Estimates, Ups FCF View
by Zacks Equity Research
General Electric's (GE) third-quarter 2019 earnings rise year over year on improved margin profile. It raises the free cash flow (Industrial) view for 2019.
Yes, You Can Time the Market. Find out How - October 28, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Danaher (DHR) Beats Q3 Earnings Estimates, Lowers '19 View
by Zacks Equity Research
Danaher's (DHR) third-quarter 2019 earnings benefit from organic sales growth, acquisitions and DBS initiatives. It lowers 2019 projection, accounting for the Envista transaction.
Danaher (DHR) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 0.87% and -0.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Danaher (DHR) Ahead of Earnings?
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Danaher (DHR) Keep Earnings Beat Streak Alive in Q3?
by Zacks Equity Research
Danaher's (DHR) third-quarter earnings are expected to reflect the impact of Danaher Business System, acquired assets, solid product offerings and innovation. Forex and cost woes remain.